Business ❯Pharmaceuticals ❯Drug Development

Alzheimer's Treatment

Kisunla FDA Approval

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab